Boston Scientific Corporation ( NYSE: BSX) TD Cowen 45th Annual Healthcare Conference March 4, 2025 9:10 AM ET Dan Brennan - Chief Financial Officer Ken Stein - Chief Medical Officer Art Butcher - ...

Boston Scientific (BSX) has agreed to acquire medical device company SoniVie for around $360M upfront payment.

Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular ultrasound system developer SoniVie.

Boston Scientific is diving into the field of renal denervation, with a $540 million deal for SoniVie and its ...

Marlborough medical device manufacturer Boston Scientific has entered into a purchase agreement worth up to half a billion ...

Boston Scientific Corporation announced it has entered into a definitive agreement to acquire SoniVie Ltd., a privately held ...

In a wide manufacturing room with white walls and low ceilings, Boston Scientific employees combine components into finished ...

SoniVie has been supported by Andera Partners since 2023. Boston Scientific has entered into a definitive agreement to acquire SoniVie from Andera Partners.

Boston Scientific Corp. closed 2.30% below its 52-week high of $107.17, which the company reached on February 5th.

Boston Scientific has gained a duo of CE markings in the European Union (EU) for its navigation enabled Farawave NAV Ablation Catheter for paroxysmal atrial fibrillation (AF) treatment and its new ...

Despite the Marlborough medical device firm’s recent dealmaking hot streak, it says the growth in number of employees isn't due only to acquisitions. Boston Scientific Corp. grew its headcount ...